Search Results
112 results
Your search is now limited to «Genentech» expert search.
Reuters.com 01/09/2019 08:37
OncBioMune Pharmaceuticals Inc:
More from Reuters.com:
GlobeNewswire 01/09/2019 08:28
BATON ROUGE, La., Jan. 09, 2019 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary therapeutic cancer vaccine immunotherapy and targeted cancer therapies, today announces that its Board of Directors has appointed Brian Barnett, M.D., as Chief Executive Officer.
Adaptive Biotechnologies has entered into a worldwide collaboration and license agreement with Roche Group’s Genentech to develop, manufacture and commercialize novel neoantigen directed T-cell therapies for the treatment of a range of cancers.
More from Pharmaceutical Business Review:
WN.com 01/04/2019 13:14
Adaptive Biotechnologies to Enter into Worldwide Collaboration and License Agreement with Genentech to Develop Personalized Cellular Therap... Adaptive Biotechnologies ......
More from WN.com:
Business Wire 01/04/2019 09:00
The collaboration will combine Genentech’s global cancer immunotherapy research and development leadership with Adaptive’s proprietary T-cell receptor (TCR) discovery and immune profiling platform (TruTCR™) to accelerate a transformational new treatment paradigm of tailoring cellular therapy for each patient’s individual ...
More from Business Wire:
Industrial Info 01/03/2019 02:27
After it was first acquired by Germany's Roche back in 2010, Genentech seemingly enjoyed a certain autonomy in its operational decisions. That doesn't seem to be the case any longer. The latest announcement of 86 jobs scrapped was preceded by the initial cut of 130 at Vacaville, California, in 2017, and the orders from headquarters last August to lay off 223 in South San Francisco, California. The lost jobs encompass a wide variety of positions.
Genentech, a member of the Roche Group announced data from the primary analysis of the Phase III HAVEN 2 study evaluating Hemlibra® prophylaxis in children younger than 12 years of age with hemophilia A with factor ...
More from Hemophilia Federation of America:
Contract Pharma 12/17/2018 08:49
Proteostasis Therapeutics has entered a worldwide, exclusive license agreement with Genentech , a member of the Roche Group , for rights to potential therapeutic small molecule modulators of an undisclosed target within the proteostasis network.
More from Contract Pharma:
Company Drug/Device Medical Condition Status Innovent Biologics, Inc. IBI101, a recombinant fully human anti-OX40 monoclonal antibody (mAb) drug candidate Advanced solid tumors FDA approved Investigational New Drug (IND) application and plans to initiate Phase I clinical trial based on results from China Phase I trial Sunny Pharmtech, Inc. and Vitruvius Therapeutics, Inc. Aminocaproic Acid Tablets [...]. T.
More from CenterWatch Clinical Trials Today Headlines:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications